Risk, Prevalence and Survival Outcomes of Ovarian Cancer in Women With Endometriosis: The Endocancer Systematic Review and Meta-Analysis

Ilaria Piacenti, Piacenti I, Tius V, Veronica Tius, Gomba B, Benedetta Gomba, Stefano Restaino, Martina Arcieri, Zermano S, Silvia Zermano, Biasioli A, Anna Biasioli, Federica Perelli, Diego Raimondo, Lucia Lazzeri, Alberto Mattei, Mattei A, Errico Zupi, Zupi E, Seracchioli R, Renato Seracchioli, Giuseppe Vizzielli
Journal of Minimally Invasive Gynecology · 2026 · vol. 33(9) , pp. 1251–1262 · doi:10.1016/j.jmig.2026.04.021 · PMID:42102910 · W7160442845
Systematic review / meta-analysis OA: hybrid CC-BY-4.0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This meta-analysis found endometriosis increases ovarian cancer risk, with EAOC patients presenting younger, with earlier-stage and low-grade tumors, and exhibiting better overall survival.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: Endometriosis is linked to an increased risk of epithelial ovarian cancer (EOC), especially clear cell and endometrioid subtypes. The extent and prognostic significance of this link are still not fully understood. This systematic review and meta-analysis compiles existing evidence on ovarian cancer risk, histotype distribution, and survival outcomes in women with endometriosis. DATA SOURCES: Systematic search up to August 2025. METHODS OF STUDY SELECTION: A systematic search of PubMed and Google Scholar was performed up to August 2025. Studies reporting ovarian cancer risk estimates or survival outcomes in endometriosis-associated ovarian cancer (EAOC) were included. Random-effects models generated pooled odds ratios (OR), hazard ratios (HR), and standardized incidence ratios (SIR). Risk analyses included >500 000 women; survival analyses >10 000. TABULATION, INTEGRATION, AND RESULTS: Sixty-seven studies met inclusion criteria. Endometriosis increased ovarian cancer risk (OR: 1.82, HR: 3.03, SIR: 1.62). EAOC patients were younger, more often premenopausal, and more frequently diagnosed with early-stage (OR: 0.29) and low-grade tumors (OR: 1.71). Clear cell and endometrioid histotypes predominated. Overall survival was significantly better in EAOC (HR: 0.48); recurrence and mortality were lower, while platinum resistance was similar. CONCLUSION: Endometriosis confers an increased relative but still low absolute risk of ovarian cancer. EAOC exhibits distinct clinicopathologic features and improved survival compared with non-EAOC. These findings support personalized counseling and emphasize the need for phenotype-based risk stratification and molecular markers of malignancy transformation.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial Carcinoma, Ovarian Epithelial

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (77)

Cited by (3)

SciLite annotations

chemicals 1
platinum

Source provenance

europepmc
last seen: 2026-10-15T06:08:49.021275+00:00
openalex
last seen: 2026-07-31T06:01:29.331002+00:00
pubmed
last seen: 2026-10-15T06:03:04.775061+00:00
scilite
last seen: 2026-07-19T09:54:07.271699+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine